Receiving Hemodialysis(혈액투석 받기)란 무엇입니까?
Receiving Hemodialysis 혈액투석 받기 - Methods: We enrolled patients who had been receiving hemodialysis for >3 months. [1] 5 g/dl) receiving hemodialysis at a medium-sized dialysis organization. [2] The case subject was an 80-year-old man who had diabetes mellitus and who was receiving hemodialysis and anticoagulant therapy. [3] A 56-year-old lady had been receiving hemodialysis through the femoral line. [4] A large body of evidence has shown that there is a bidirectional relationship between thyroid dysfunction and kidney disease, yet there are many remaining gaps in knowledge in regards to the clinical management of CKD patients with hypothyroidism, including those receiving hemodialysis and peritoneal dialysis. [5] INTRODUCTION The accuracy of hemoglobin A1c (HbA1c) as a glycemic marker in patients with type 2 diabetes (T2D) receiving hemodialysis (HD) remains unknown. [6] Among the 1000-odd patients who were receiving hemodialysis, 350 were studied using convenience sampling. [7] Methods A systematic review of randomized trials reporting physical fitness outcomes in adults with CKD (not requiring kidney replacement therapy) receiving hemodialysis (HD) or peritoneal dialysis and kidney transplant recipients was conducted. [8] The patients with CAC were older, receiving hemodialysis, lower Kt/V, and had longer dialysis vintage, as well as higher levels of serum 25-(OH)-vit D and sclerostin. [9] About 44 (88%) patients received a blood transfusion during their hemodialysis sessions and 14 (28%) patients had a history of receiving hemodialysis at other centres. [10] BACKGROUNDS AND AIMS The geriatric nutritional risk index (GNRI), which is calculated using the serum albumin level and body mass index, is a nutritional marker associated with an increased risk of cardiovascular events in patients who are receiving hemodialysis. [11] Managing HTN with agents that block the renin angiotensin aldosterone system (RAAS) remains the gold standard, however there is a misleading impression that patients with impaired renal function or those receiving hemodialysis should not be treated with RAAS inhibitors. [12] Therefore, this study conducted a retrospective cohort analysis on all patients diagnosed with ESKD and receiving hemodialysis, investigating whether the type of their diagnosis for hospital admission changed before and after they started hemodialysis. [13] 001), the burden of “not receiving hemodialysis on time” (β = 0. [14] 5% were receiving hemodialysis. [15] The aim of this study was to identify and compare some variables that could be associated with mortality in CKD patients whether receiving hemodialysis or in a conservative approach. [16]방법: 3개월 이상 혈액투석을 받은 환자를 등록하였다. [1] 5g/dl) 중형 투석 기관에서 혈액 투석을 받고 있습니다. [2] 증례 대상자는 당뇨병이 있는 80세 남성으로 혈액투석과 항응고제 치료를 받고 있었다. [3] 56세 여자가 대퇴부를 통해 혈액투석을 받고 있었다. [4] 갑상선 기능 저하증과 신장 질환 사이에 양방향 관계가 있다는 많은 증거가 있지만 혈액 투석 및 복막 투석을 받는 환자를 포함하여 갑상선 기능 저하증이 있는 CKD 환자의 임상 관리와 관련하여 지식에 많은 격차가 남아 있습니다. [5] 소개 혈액투석(HD)을 받는 제2형 당뇨병(T2D) 환자의 혈당 표지자로서의 헤모글로빈 A1c(HbA1c)의 정확도는 아직 알려지지 않았습니다. [6] 혈액투석을 받고 있던 1000명의 홀수 환자 중 350명을 편의표집법으로 연구했다. [7] 방법 혈액 투석(HD) 또는 복막 투석을 받고 있는 성인 CKD(신장 대체 요법이 필요하지 않음) 및 신장 이식 수혜자의 체력 결과를 보고한 무작위 시험에 대한 체계적인 검토가 수행되었습니다. [8] CAC 환자는 더 나이가 많았고 혈액 투석을 받았고 Kt/V가 낮았으며 투석 기간이 더 길었고 혈청 25-(OH)-vit D 및 sclerostin 수치가 더 높았습니다. [9] 약 44명(88%)의 환자가 혈액투석 기간 동안 수혈을 받았고 14명(28%)의 환자가 다른 센터에서 혈액투석을 받은 이력이 있었습니다. [10] 배경 및 목표 혈청 알부민 수치와 체질량 지수를 사용하여 계산되는 GNRI(노인 영양 위험 지수)는 혈액 투석을 받는 환자에서 심혈관 사건의 위험 증가와 관련된 영양 지표입니다. [11] 레닌 안지오텐신 알도스테론계(RAAS)를 차단하는 약물로 HTN을 관리하는 것은 여전히 표준이지만, 신장 기능이 손상된 환자나 혈액 투석을 받는 환자는 RAAS 억제제로 치료해서는 안 된다는 잘못된 인상이 있습니다. [12] 따라서 본 연구에서는 ESKD로 진단되어 혈액투석을 받고 있는 모든 환자를 대상으로 후향적 코호트 분석을 수행하여 혈액투석을 시작하기 전과 후에 입원 진단 유형이 변화했는지를 조사하였다. [13] 001), “제시간에 혈액투석을 받지 못하는” 부담(β = 0. [14] 5%는 혈액투석을 받고 있었다. [15] 이 연구의 목적은 혈액투석을 받든 보존적 접근을 하든 CKD 환자의 사망률과 관련될 수 있는 몇 가지 변수를 확인하고 비교하는 것이었습니다. [16]
end stage renal 말기 신장
Background/Aim: Malnutrition is one of the determinants of most morbidity and mortality in end-stage renal failure (ESRD) patients receiving hemodialysis (HD). [1] Cardiovascular diseases are the leading cause of mortality in end-stage renal disease (ESRD) patients, especially those receiving hemodialysis (HD) therapy. [2] Introduction Elevation of cardiac troponin I (cTn-I) is associated with coronary artery disease (CAD) in asymptomatic patients with end-stage renal disease (ESRD) receiving hemodialysis. [3] OBJECTIVE This study aimed to assess subjective sleep and wake disorders (SWD) in patients with osteoarthritis and comorbid end-stage renal disease (ESRD) receiving hemodialysis (ESRD-HD) compared to patients with osteoarthritis and without chronic kidney disease (CKD) as well as to clarify of the association of subjective sleep characteristics with the levels of anxiety and depression and pain, general health score and laboratory parameters in these cohorts. [4] Therefore, this study was conducted to examine variations in mortality and hospitalization cases among end-stage renal disease (ESRD) patients receiving hemodialysis (HD) care from medical facilities located in 13 secondary medical care areas (SMAs) of Fukuoka prefecture, Japan. [5] The aim of this study was to explore the socio-demographic aspects of end- stage renal disease (ESRD) patients receiving hemodialysis, the clinical characteristics of such patients, and to assess their appetite and its impact on daily dietary intake. [6] INTRODUCTION The characteristics in dialyzer is associated with mortality in patients with end-stage renal disease (ESRD) receiving hemodialysis (HD). [7] In the second patient receiving hemodialysis treatment for end-stage renal disease, hyperparathyroidism spontaneously resolved after FNAB and the parathyroid hormone (PTH) levels normalized after surgery. [8] Introduction: Bloodstream infections (BSI) are the second commonest cause of morbidity and mortality in end stage renal failure (ESRF) patients Dialysis catheters are believed to be the most common contributors to BSI in this cohort Therefore, patients who are receiving hemodialysis via long term central venous catheters (CVC) are at significantly high risk of CRBSI and its associated morbidity and mortality Although there are several studies on CRBSI from different cohorts around the world, long-term follow up data are scarce particularly from middle eastern cohorts We aim to fill this knowledge gap as well as to develop an antibiogram and antibiotic stewardship for this unique cohort of patients Methods: This is a single center retrospective longitudinal study of a middle eastern cohort receiving three times a week regular hemodialysis via permanent CVC in a large out-patient setting We analyzed all the data from December 2015 to November 2020 Data on incidents of CRBSI, etiology, antimicrobial susceptibility, CRBSI risk factors, and comorbidities were collected For the sake of our study, we defined CRBSI with the isolation of the same microorganism from the CVC and peripheral blood culture without any other apparent source The incidence of CRBSI was expressed as incidence per 1000 catheter days Results: A total of 39 incidents of CRBSI were identified during these 5 years study period Of the reported cases, 94% grew a single organism while 6% grew polymicrobial Of the multitude of organisms isolated, 39% were gram positives while the rest were gram negatives Staphylococcus aureus and enterococcus were predominant gram positives while pseudomonas and klebsiella were the predominant gram negatives No case of MRSA or fungi were isolated The distribution of organisms is illustrated in the bar chart below Interestingly only 70% of cases presented with the typical triad of fever, rigors, and exit site exudates, while around 20% presented with only hypotension 10% of the cases were completely asymptomatic and were only incidental findings The incidence of CRBSI per 1000 catheter days was calculated for every month and as illustrated by the graph below, the CRBSI rates seem quite variable throughout this study period However, interestingly, since the beginning of the COVID19 pandemic outbreak, the CRBSI rates are conspicuously low This might be explainable by enhanced focus on hand hygiene by both the staff and the patients themselves during this pandemic CRBSI incidences were higher among patients with longer duration of catheter use, previous bacteremia, old age, diabetes mellitus, and recent hospitalization [Formula presented] [Formula presented] Conclusions: The incidence of CRBSI reported from our center seems to be comparable to other international centers around the world The causative microorganisms and their antibiotic susceptibilities also seem to be in concordance with the rest of the world despite variations in geography, climate, and ethnicity We conclude, that irrespective of the differences in the geographical location and study cohorts, strict adherence and attention to hand hygiene and infection control practices by both the staff and the patients are the keys to keeping CRBSI low No conflict of interest. [9] He had been receiving hemodialysis for 6 years because of end-stage renal failure due to antineutrophil cytoplasmic antibodies-associated glomerulonephritis. [10] Background: Hypertension is common findings in end-stage renal disease (ESRD) patients receiving hemodialysis, around two third among them are poorly controlled. [11] However, it is not known whether supplementation with EPO reduces the risk of dementia in end-stage renal disease (ESRD) patients receiving hemodialysis (HD). [12] The patient was an end-stage renal disease (ESRD) case who was receiving hemodialysis (HD) via a dual-lumen cuffed venous catheter. [13]배경/목표: 영양실조는 혈액투석(HD)을 받는 말기 신부전(ESRD) 환자의 대부분의 이환율과 사망률을 결정하는 요인 중 하나입니다. [1] 심혈관 질환은 말기 신장 질환(ESRD) 환자, 특히 혈액 투석(HD) 요법을 받는 환자의 주요 사망 원인입니다. [2] nan [3] nan [4] nan [5] nan [6] nan [7] nan [8] 서론: 혈류 감염(BSI)은 말기 신부전(ESRF) 환자의 이환율 및 사망률의 두 번째로 흔한 원인입니다. 투석 카테터는 이 코호트에서 BSI에 대한 가장 흔한 기여자로 여겨집니다. 중심 정맥 카테터(CVC)는 CRBSI 및 관련 이환율 및 사망률의 위험이 상당히 높습니다. 전 세계의 다양한 코호트에서 CRBSI에 대한 여러 연구가 있지만 특히 중동 코호트에서 장기 추적 데이터가 부족합니다. 이 지식 격차는 물론 이 독특한 환자 집단을 위한 항생체 사진 및 항생제 관리를 개발하는 방법: 이것은 대규모 외래 환자에서 영구적인 CVC를 통해 정기적인 혈액 투석을 일주일에 3번 받는 중동 집단에 대한 단일 센터 후향적 종단 연구입니다. 설정 2015년 12월부터 2020년 11월까지의 모든 데이터를 분석했습니다. CRBSI, 병인, 세균성 감수성, CRBSI 위험 인자 및 동반 질환이 수집되었습니다. 본 연구를 위해 다른 명백한 출처 없이 CVC 및 말초 혈액 배양에서 동일한 미생물을 분리하여 CRBSI를 정의했습니다. 카테터 일 결과: 이 5년의 연구 기간 동안 총 39건의 CRBSI 사건이 확인되었습니다. 보고된 사례 중 94%는 단일 유기체로 성장한 반면 6%는 다중 미생물로 성장했습니다. 분리된 많은 유기체 중 39%는 그람 양성이었고 나머지는 그람 양성이었습니다. 그람 음성은 황색포도상구균과 장구균이 그람 양성이었으며 슈도모나스와 클렙시엘라는 그람 음성이 우세했습니다. 열, 경직 및 출구 부위 삼출물이 나오는 반면 약 20%는 저혈압이 10%만 나타납니다. e 증례는 완전히 무증상이었고 단지 부수적 발견일 뿐이었습니다. 1000 카테터 일당 CRBSI 발생률은 매월 계산되었으며 아래 그래프에서 볼 수 있듯이 CRBSI 비율은 이 연구 기간 동안 상당히 가변적인 것처럼 보이지만 흥미롭게도 1000 카테터 일 시작 이후 COVID19 대유행 발생, CRBSI 비율이 현저히 낮습니다. 이는 이번 대유행 기간 동안 직원과 환자 모두의 손 위생에 대한 관심이 높아졌기 때문에 설명될 수 있습니다. CRBSI 발생률은 카테터 사용 기간이 더 긴 환자, 이전 균혈증, 노년, 당뇨병, 최근 입원 [수식 제시] [수식 제시] 결론: 우리 센터에서 보고된 CRBSI의 발병률은 전세계 다른 국제 센터와 유사한 것으로 보입니다. 지리, 기후 및 민족의 변화에도 불구하고 세계의 나머지 지역 icity 우리는 지리적 위치와 연구 집단의 차이와 상관없이 직원과 환자 모두의 손 위생 및 감염 통제 관행에 대한 엄격한 준수와 주의가 CRBSI를 낮게 유지하는 열쇠라고 결론지었습니다. 이해 상충 없음. [9] nan [10] nan [11] nan [12] nan [13]
chronic kidney disease 만성 신장 질환
Background Patients with chronic kidney disease, especially those receiving hemodialysis (HD), are at risk of hyperkalemia (HK). [1] The burden of chronic kidney disease and hemodialysis is increasing in Ethiopia, but few studies explored the lived experiences of chronic kidney disease patients receiving hemodialysis. [2] 11) in patients with chronic kidney disease receiving hemodialysis as compared to the values of the same variables in the control group. [3] The first experience of complicated arteriovenous fistulas liquidation using endovasal laser obliteration in 6 patients receiving hemodialysis replacement therapy for stage 5 chronic kidney disease (National kidney Foundation (NkF) classification) is presented. [4] We performed a retrospective analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database at a single institution for patients with chronic kidney disease receiving hemodialysis therapy (CKD G5D) undergoing bariatric surgery between 2011 and 2018. [5] Background Chronic kidney disease is associated with chronic inflammation and progressive loss of peripheral muscle strength and the ability to exercise, and these changes are highly pronounced in patients receiving hemodialysis (HD). [6] There is no single gold standard method for assessment of the nutritional status of chronic kidney disease patients and so it is better to use multiple methods of assessment for the patients including history taking and dietary assessment via diaries and questionnaires, anthropometric measurements including body mass index calculation , laboratory testing and body composition assessment Aim of the work:The aim of the present work is to study the nutritional status of the patients receiving maintenance hemodialysis sessions using the body composition monitor devicePatients and methods:This study was conducted over 50 patients receiving hemodialysis sessions in El Moassah university hospital after applying the exclusion criteria and they were subjected to : 1. [7] SAE could be considered as supportive therapy in patients receiving hemodialysis which are prone to oxidative stress caused by both chronic kidney disease and hemodialysis procedure. [8] Case presentation: A 44-year-old patient with a previous diagnosis of chronic kidney disease receiving hemodialysis secondary to polycystic kidney disease, with a history of parathyroidectomy due to primary hyperparathyroidism in 2011. [9] Valvular heart calcification is common in patients with chronic kidney disease (CKD), especially in those receiving hemodialysis therapy, and it is associated with poor prognosis. [10] There is only limited information on the functional status (FS) of patients receiving hemodialysis (HD) from developing countries where the etiology of chronic kidney disease (CKD) and demographic profile are different. [11]배경 만성 신장 질환이 있는 환자, 특히 혈액투석(HD)을 받는 환자는 고칼륨혈증(HK)의 위험이 있습니다. [1] 에티오피아에서 만성신장질환과 혈액투석의 부담이 증가하고 있지만 혈액투석을 받는 만성신장질환 환자의 생생한 경험을 조사한 연구는 거의 없었다. [2] 11) 혈액투석을 받고 있는 만성신장질환 환자에서 대조군과 동일한 변수의 값을 비교하였다. [3] nan [4] 우리는 2011년과 2018년 사이에 비만 수술을 받고 있는 혈액 투석 요법(CKD G5D)을 받는 만성 신장 질환 환자를 대상으로 단일 기관에서 대사 및 비만 수술 인증 및 품질 개선 프로그램 데이터베이스의 후향적 분석을 수행했습니다. [5] nan [6] nan [7] nan [8] nan [9] nan [10] nan [11]
health related quality 건강 관련 품질
Introduction Whether clinically implementable exercise interventions in people receiving hemodialysis (HD) therapy improve health-related quality of life (HRQoL) remains unknown. [1] Objective: To identify how resilience, health- related quality of life, and sociodemographic, clinical, and hemodialysis routine-related variables are related to perceived stress in patients with chronic kidney disease receiving hemodialysis for more than six months. [2] METHODS Patients receiving hemodialysis treatment three times a week for at least six months were evaluated using STS-30, Incremental Shuttle Walking Test, and health-related quality of life by KDQOL-SF questionnaire. [3]서론 혈액투석(HD) 요법을 받는 사람들에게 임상적으로 시행 가능한 운동 중재가 건강 관련 삶의 질(HRQoL)을 개선하는지 여부는 아직 알려지지 않았습니다. [1] 목적: 회복력, 건강 관련 삶의 질, 사회인구학적, 임상적, 혈액투석 일상 관련 변수가 6개월 이상 혈액투석을 받는 만성 신장 질환 환자의 스트레스 인지와 어떻게 관련되는지 확인합니다. [2] nan [3]
Patient Receiving Hemodialysis 혈액투석을 받고 있는 환자
Results The percentage of CA-AKI patients receiving hemodialysis was 10. [1] METHODS A linked database of clinical records and medical claims for patients receiving hemodialysis in a large dialysis organization, 2007-2010, was used. [2] Background/Aim: Malnutrition is one of the determinants of most morbidity and mortality in end-stage renal failure (ESRD) patients receiving hemodialysis (HD). [3] After exclusion criteria, 363 patients receiving PD and 5302 patients receiving hemodialysis were analyzed. [4] Cardiovascular disease is the leading cause of death for patients receiving hemodialysis. [5] The burden of chronic kidney disease and hemodialysis is increasing in Ethiopia, but few studies explored the lived experiences of chronic kidney disease patients receiving hemodialysis. [6] Background Patients receiving hemodialysis (HD) often experience multiple symptoms concurrently and these symptoms may impact their quality of life. [7] Poor self-care in patients receiving hemodialysis is associated with an increased risk of mortality and hospitalization. [8] Since the onset of the COVID‐19 pandemic, efforts to encourage home‐based dialysis options have increased due to risks of infective transmission for patients receiving hemodialysis in center‐based units. [9] AIM Elevated serum alkaline phosphatase (ALP) levels have been associated with increased risks of all-cause and cardiovascular mortality in patients receiving hemodialysis. [10] To the Editor: Heart failure with reduced ejection fraction is a significant cause of morbidity and mortality in patients receiving hemodialysis. [11] Pruritus has a negative impact on the quality of life of patients receiving hemodialysis. [12] Interventional nephrology (IN) is one of the prominent nephrology fields that mainly copes with the diagnosis and treatment of patients with renal failure by using special techniques, such as ultrasonography of kidneys, performance of kidney biopsy, insertion of peritoneal dialysis catheters, tunneled dialysis catheters, and maintenance of vascular access for patients receiving hemodialysis. [13] Beside mortality, with this study we aim to evaluated patient-outcomes (hospitalization, falls and functional capacity) in older and frailer stage 5 CKD patients receiving hemodialysis (HD) and in CM. [14] The first experience of complicated arteriovenous fistulas liquidation using endovasal laser obliteration in 6 patients receiving hemodialysis replacement therapy for stage 5 chronic kidney disease (National kidney Foundation (NkF) classification) is presented. [15] The prevalence of torus mandibularis in patients receiving hemodialysis in this study was 7. [16] CONCLUSIONS In our study group, suspected carotid artery calcifications were detected on panoramic radiographs in about one-fourth of total patients receiving hemodialysis. [17] Background and objectives: An arteriovenous fistula is considered to be an ideal vascular access for patients receiving hemodialysis, its main limitation is its high failure rate to achieve maturation and long-term functionality loss. [18] BACKGROUND Heart failure is a common and deadly complication in patients receiving hemodialysis and is difficult to diagnose and treat. [19] Conclusions The key finding of this article suggests a high prevalence of risk factors for foot ulceration among diabetic patients receiving hemodialysis. [20] Participants: Patient partners in hemodialysis research, defined as patients with personal experience of dialysis or a family member who had experience supporting a patient receiving hemodialysis, who have been actively involved in discussions to advise a research team on the design, conduct, or implementation of a hemodialysis trial. [21] BACKGROUND Patients receiving hemodialysis treatment are among the risk groups during the COVID-19 pandemic. [22] Background Family caregivers of patients receiving hemodialysis experience physical and psychological disorders. [23] In this perspective article, we will describe: 1) the role of primary care for patients receiving maintenance hemodialysis and the current evidence regarding the receipt of primary care among those patients; 2) the key challenges to delivery of primary care for these complex patients, including suboptimal care coordination between nephrology and primary care providers (PCPs), the intensity of dialysis care, and the limited capacity of nephrologists and PCPs to meet the broad health needs of hemodialysis patients; 3) the potential strategies for improving the delivery of primary care for patients receiving hemodialysis; and 4) future research needs to improve primary care delivery for this high-risk population. [24] It is sometimes difficult to promptly diagnose infective endocarditis when a patient receiving hemodialysis presents with signs and symptoms of bacteremia, a delay which can lead to worse outcomes. [25] Therefore, this study was conducted to examine variations in mortality and hospitalization cases among end-stage renal disease (ESRD) patients receiving hemodialysis (HD) care from medical facilities located in 13 secondary medical care areas (SMAs) of Fukuoka prefecture, Japan. [26] OBJECTIVE This meta-analysis was to assess the effect of fish oil supplementation on inflammation markers in adult patients receiving hemodialysis. [27] Methods This 52-week, randomized, double-blinded, double-dummy study compared the efficacy and safety of molidustat and darbepoetin in Japanese patients receiving hemodialysis and erythropoiesis-stimulating agents. [28] The effect of hemodialysis on individual organ perfusion in pediatric versus adult patients receiving hemodialysis might differ. [29] Background and objectives: An arteriovenous fistula is considered to be an ideal vascular access for patients receiving hemodialysis, its main limitation is its high failure rate to achieve maturation and long-term functionality loss. [30] Objective: To explore the application value of high-quality services in the nursing of senile diabetic nephropathy (SDN) patients receiving hemodialysis. [31] SNF472 has completed early phase clinical trials with a favourable safety profile and Phase 2 clinical trial data have shown attenuation of coronary artery and aortic valve calcification in patients receiving hemodialysis. [32] Background Kidney transplant recipients and patients receiving hemodialysis are immunocompromised populations that are prioritized for COVID-19 vaccination but were excluded from clinical trials of SARS-CoV-2 mRNA vaccines. [33] The aim of this study was to explore the socio-demographic aspects of end- stage renal disease (ESRD) patients receiving hemodialysis, the clinical characteristics of such patients, and to assess their appetite and its impact on daily dietary intake. [34] Objective: To evaluate the effectiveness of using midodrine in patients receiving hemodialysis concerning the incidence of IDH. [35] Design, setting, participants, and measurements: We enrolled nondiabetic patients receiving hemodialysis for more than 3 months and had inadequate dietary energy intake (<30kcal/kg/d). [36] Background Chronic kidney disease is associated with chronic inflammation and progressive loss of peripheral muscle strength and the ability to exercise, and these changes are highly pronounced in patients receiving hemodialysis (HD). [37] DISCUSSION This multicenter study found that the incidence of delayed bleeding after ESD in Japanese patients older than 80 years was high, especially in patients receiving hemodialysis and taking warfarin. [38] In this study, we investigated the predictive ability of a combination of cardiothoracic ratio (CTR) and aortic arch calcification (AoAC) for overall and cardiovascular mortality in patients receiving hemodialysis. [39] Patients receiving hemodialysis (HD) are at risk of TB development. [40] In the second patient receiving hemodialysis treatment for end-stage renal disease, hyperparathyroidism spontaneously resolved after FNAB and the parathyroid hormone (PTH) levels normalized after surgery. [41] In the current study, we investigated the extent of endothelial activation in patients receiving hemodialysis who had either mild or severe COVID‐19. [42] Purpose of this research is to know the related factors towards the obedience in limiting fluid intake on the patients receiving hemodialysis at Bakti Timah Hospital Pangkalpinang. [43] There is no single gold standard method for assessment of the nutritional status of chronic kidney disease patients and so it is better to use multiple methods of assessment for the patients including history taking and dietary assessment via diaries and questionnaires, anthropometric measurements including body mass index calculation , laboratory testing and body composition assessment Aim of the work:The aim of the present work is to study the nutritional status of the patients receiving maintenance hemodialysis sessions using the body composition monitor devicePatients and methods:This study was conducted over 50 patients receiving hemodialysis sessions in El Moassah university hospital after applying the exclusion criteria and they were subjected to : 1. [44] One dose of the BNT162b2 SARS-CoV-2 vaccine is efficacious in the general population, but responses in patients receiving hemodialysis are uncertain. [45] The present study was conducted to determine the effect of spiritual care on the anxiety and depression levels of patients receiving hemodialysis treatment. [46] METHODS Patients receiving hemodialysis treatment three times a week for at least six months were evaluated using STS-30, Incremental Shuttle Walking Test, and health-related quality of life by KDQOL-SF questionnaire. [47] Patients receiving hemodialysis are susceptible to many complications like hyperglycemia, inflammation, depression, anxiety, and poor quality of life. [48] Background Uremic pruritus (UP) is a common and frustrating symptom in patients receiving hemodialysis (HD). [49] Our findings suggest that body composition parameters, whether measured before or after dialysis could be useful in assessing dyslipidemia in patients receiving hemodialysis. [50]결과 혈액투석을 받은 CA-AKI 환자의 비율은 10명이었습니다. [1] 행동 양식 2007-2010년에 대규모 투석 기관에서 혈액 투석을 받는 환자에 대한 임상 기록 및 의료 청구의 연결 데이터베이스가 사용되었습니다. [2] 배경/목표: 영양실조는 혈액투석(HD)을 받는 말기 신부전(ESRD) 환자의 대부분의 이환율과 사망률을 결정하는 요인 중 하나입니다. [3] nan [4] nan [5] 에티오피아에서 만성신장질환과 혈액투석의 부담이 증가하고 있지만 혈액투석을 받는 만성신장질환 환자의 생생한 경험을 조사한 연구는 거의 없었다. [6] nan